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CASE REPORTThe Journal of Critical Care Medicine 2017;3(3):120-122
Raoultella ornithinolytica Diagnosed in a  
Neurointensive Patient. A Rare Case with  
Recovery without Antibiotics
Marlene Ersgaard Jellinge*
Department of Anesthesiology and Intensive Care Medicine, Odense University Hospital, Denmark
Abstract
Infection with Raoultella ornithinolytica is rare and normally the infection is present in patients with underlying ma-
lignancies or chronic diseases. It is normally treated with antibiotics. In this case report, a neuro-intensive patient 
without malignancies or other severe chronic diseases was colonized with Pseudomonas aeruginosa but infected 
with Raoultella ornithinolyca. The patient recovered without treatment with antibiotics.
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 Introduction
Infection with Raoultella ornithinolytica is rare and this 
Gram-negative, oxidase-negative, non-motile, capsu-
lated facultative anaerobic bacillus of the enterobac-
teriaceae family is normally found in aquatic environ-
ments, fish and insects [1-11].
Raoultella ornithinolytica occurs mainly in patients 
with underlying malignancies or chronic diseases, 
trauma, nosocomial infection and invasive procedures 
and is a risk factor for a poor outcome [1,4,8-9,12]. The 
bacterium was originally named Klebsiella ornithino-
lytica but was subsequently reclassified as Raoultella 
ornithinolytica. It is an important histamine-producing 
bacterium associated with distinctive cutaneous signs 
consisting of flushing or a maculopapular rash [3,6-
7,10-13]. 
Raoultella ornithinolytica is a rarely reported hos-
pital-acquired infection [9]. It is occasionally isolated 
from bronchial lavage or other deep respiratory sam-
ples and should never be considered simply a sapro-
phytic bacterium. It shows a high resistance to antimi-
crobial resistance [9-10] and it has been reported that 
it may cause a fatal neonatal infection, especially in 
preterm infants [12].
The present report concerns a patient in a neuro-
intensive care unit who had been diagnosed with the 
colonization of the trachea by Raoultella ornithinolytica 
and who recovered without antibiotic treatment. Writ-
ten informed consent to publish this report was re-
ceived from the patient and her husband.
 Case report
A 48-year-old woman with hypertension was admit-
ted to the emergency department in Odense University 
Hospital, Odense, Denmark, with subarachnoid haem-
orrhage associated with the internal carotid artery. She 
was treated with a stent and coiling technique. After a 
period of rehabilitation in hospital, she made signifi-
cant progress and was discharged. 
Two months later she suffered a second subarachnoid 
hemorrhage with bleeding into the brain ventricles and 
hydrocephalus due to a dissection of an aneurysm in 
the internal carotid artery. She was treated using the 
endovascular coiling technique. She was admitted to 
the Department of Neuro-intensive Care in the same 
hospital and sedated with propofol 9 ml/h (20 mg/ml). 
Later this treatment was changed and she was sedated 
with sodium thiopental 7 ml/h (25 mg/ml), fentanyl 6 
ml/h (50 mcg/ml) and midazolam 10 ml/h (50 mg/ml). 
An external ventricular drain was placed together with 
a Camino® Micro Ventricular Bolt Intracranial Pres-
sure Temperature Monitoring Kit (Integra Camino, 
San Diego, USA).
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Endovascular coiling was undertaken and twenty-
five days after readmission she underwent a percutane-
ous dilatational tracheostomy to provide a long-term 
route for mechanical ventilation. The sedation pro-
cedure was reduced over time and she slowly made 
progress. Maintaining normal blood pressure was a 
challenge but otherwise she had no other organ dys-
functions.
Four days after the tracheostomy, a positive test was 
obtained for multi-resistant Pseudomonas from sam-
ples from her trachea. A decision was taken to change 
the tracheostomy tube and to isolate the patient as part 
of the infection control regime. Furthermore, it was 
elected only to prescribe antibiotics if symptoms of in-
fection occurred. The tracheostomy tube was changed 
to a Bivona® Adult TTSTM tracheotomy size 7.0 with 
cuff (Smiths Medical, Kent, UK).
On day thirty-seven after readmission, and nine days 
after the change of the tracheostomy tube, the patient 
became febrile. There was no evidence of flushing or 
rash. A blood transfusion had not been given and the 
laboratory data revealed a C-reactive protein level of 15 
mg/L and a white blood cell count of 17.5 x 109/L (Ta-
ble 1, Laboratory data). However, Gram-negative bacil-
li were cultured from the patient’s trachea, along with 
Pseudomonas. The hospital’s clinical department of mi-
crobiology identified these as Raoultella ornithinolytica 
using the matrix-assisted laser desorption/ionization 
time-of-flight mass spectrometry (MALDI-TOF MS) 
(Bruker Daltronics Biotyper 3.1). Microbe identifica-
tion and antibiotic susceptibility tests were performed 
by disk diffusion and the organism was shown to be 
sensitive to cefuroxime, gentamicin and ciprofloxacin 
but resistant to ampicillin. The next day a new sample 
was sent to the microbiology department and Raoul-
tella ornithinolytica was identified for the second time, 
still together with a high number of Pseudomonas. This 
time they were resistant to ampicillin and piperacillin/
tazobactam. The recommendation was to start treat-
ment with antibiotics only if she showed symptoms 
of infection. In accordance with this advice, antibiot-
ics were withheld and on day three and four after the 
first test result with Raoultella ornithinolytica, tracheal 
swabs were found to be negative.
Forty-nine days after the second subarachnoid 
hemorrhage and eleven days after the identification 
of Raoultella ornithinolytica, the patient was able to 
breathe spontaneously. The tracheostomy tube was re-
moved and she was discharged from the intensive care 
unit to a general ward. The patient made slow but con-
tinuous progress. She was paralyzed on the left side of 
her body, suffered from nausea and headaches, found 
it difficult to concentrate and spoke only a few words. 
Later she was discharged to a neurological rehabilita-
tion clinic where she had regained almost all of her 
neurocognitive functions although she still had mem-
ory problems. At the end of the rehabilitation program 
she was discharged to her home.
 Discussion
Most case reports of Raoultella ornithinolytica con-
cern patients with serious comorbidities. In one study, 
the mortality rate related to infection was found to be 
5% [10]. 
The patient in the present case had a previous history 
of arterial hypertension but no malignancies or other 
chronic diseases and was otherwise in good physical 
condition, fit and non-smoking. This differs from the 
descriptions of patients reported to be infected with 
Raoultella ornithinolytica [3,5,7-11-13], though in a 
case report concerning a 21-day-old boy, the patient 
was healthy except for having a sinus venous type atrial 
septal defect [12]. 
In other case reports patients received antibiotics, 
unlike the present case where the patient was not treat-
ed with antibiotics but nevertheless recovered [3,5,7-
13]. Details of this watch-and-wait policy have not 
been found in the literature.
In a previous study [10], Raoultella ornithinolytica 
pneumonia was observed in twenty patients over a 
ninety-one-month period. Half of these cases had hos-
pital-acquired pneumonia and three had ventilator-
Table 1. Laboratory data from the department of clinical biochemistry and clinical microbiology
Date 14/4 15/4 16/4 17/4 18/4 19/4
C-reactive Protein mg/L 9.5 13 15 28 14 18
White blood cell x 109/L 9.0 14.0 17.5 9.0 8.7 12.6
Temperature °C 36.9 37.2 37.5 37.8 37.4 37.0
Raoultella ornithinolytica Negative Negative Positive Positive Negative Negative
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associated pneumonia. The patients diagnosed with 
Raoultella ornithinolytica presented a medical history 
of solid cancer, immunodeficiency, diabetes mellitus or 
chronic alcoholics [10]. This seems to be different from 
the woman in the present case report.
Identification of Raoultella species is difficult due 
to its phenotypic similarity to Klebsiella species [1,9-
11]. The MALDI-TOF MS technique, used to identify 
the bacterium in this case, has a high sensitivity and 
specificity for Raoultella ornithinolytica. The technique 
has been used to correctly and rapid identify of various 
microorganisms, including Raoultella ornithinolytica 
which often do not need confirmation by molecular 
procedures [9-10].
Accurate identification of Raoultella ornithinolytica 
and determination of antibiotics susceptibility are nec-
essary to determine appropriate patient care. Normally 
Raoultella ornithinolytica strains are sensitive to at least 
two or three different antibiotics [5], but one report has 
described that a strain was resistant to all antibiotics 
except tigecycline and colistin [14]. Raoultella species 
have the potential for multi-drug resistance [4]. The 
consensus recommendation is that a Raoultella ornithi-
nolytica infection should be treated with antibiotics e.g. 
amoxicillin plus clavulanic acid for 10-14 days [6]. 
 Conclusion
This is a case report concerning a patient in the neuro-
intensive care who was infected with Raoultella ornithi-
nolytica and the distinctive feature in this case was that 
the patient was successfully treated without antibiotics, 
suggestive of the advantage offered by a “watch-and-
wait policy”.
Raoultella ornithinolytica is a pathogen with potent 
virulence. It is very rare but should be dealt with atten-
tion. Raoultella ornithinolytica may have fatal outcome 
in patients with severe comorbidities.
The prevalence of Raoultella ornithinolytica may be 
an underreported, emerging hospital-acquired infec-
tion and early recognition and proper infection control 
measures are important. Physicians should be aware of 
the possibility of medical and surgical device-associat-
ed Raoultella ornithinolytica infections and the risk of 
antimicrobial resistance.
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